In its continued effort to improve transparency and public access to information about approved animal drugs, the U.S. Food & Drug Administration’s Center for Veterinary Medicine has launched phase 2 of the redesigned Animal Drugs @ FDA website.
As before, the new Animal Drugs website provides a searchable database for veterinarians, pet owners, animal producers and others to get information about approved animal drugs by application number, sponsor name, proprietary name, ingredient, application status, dosage form, route of administration, indication and species.
The completion of phase 2 on June 8 provides a “one-stop shop” for additional information related to approved animal drugs, including the migration of the following documents from FDA.gov:
* Freedom of Information Act summaries;
* Environmental assessments;
* Findings of no significant impact, and
* Green Book reports.
These existing documents will be transitioned from FDA.gov to Animal Drugs @ FDA over the next several months, with users being directed to the new location.
In addition, all Green Book reports will now be available immediately instead of being published annually. These “real-time” reports will be provided in PDF and Microsoft Excel formats.
For more information about the redesigned Animal Drugs @ FDA, contact [email protected].